Richard Mountfield, Ph.D.

Richard Mountfield has spent over 25 years in the biopharmaceutical industry, with experience in all stages of drug development. Most recently, he was Senior Vice President of Regulatory Affairs and Drug Development at Boston Pharmaceuticals, where he was responsible for helping build the organization, including establishing and recruiting multiple line functions and contributing to the in-licensing of numerous assets with multiple indications. Prior to that, he held positions of increasing responsibility in Regulatory Affairs and Drug Development at Celyad, Novartis, and Boehringer Ingelheim. He has also been involved in the registration and approval of multiple products in both the US and EU. Earlier in his career he was involved in late discovery and early clinical development at Roche and Novo Nordisk. Richard holds a Ph.D. in biochemistry from the University of Wales, Aberystwyth.